US approves treatment that alters patients’ cells to attack childhood leukemia – Minneapolis Star Tribune
Minneapolis Star Tribune |
US approves treatment that alters patients' cells to attack childhood leukemia
Minneapolis Star Tribune The CAR–T cell treatment developed by Novartis and the University of Pennsylvania is the first type of gene therapy to hit the U.S. market — and one in a powerful but expensive wave of custom-made "living drugs" being tested against blood cancers and … |
